Načítá se...
The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is characterised by the progressive deposition of excessive extracellular matrix proteins within the lung parenchyma and represents the most rapidly progressive and fatal of all fibrotic conditions. Current anti-fibrotic drugs approved for the treatment of IPF fai...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
European Respiratory Society
2020-10-01
|
| Edice: | European Respiratory Review |
| On-line přístup: | http://err.ersjournals.com/content/29/157/200269.full |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|